Q1 Sales & Earnings: An Opportunity For Clarity In An Uncertain Time

Johnson & Johnson is the first big pharmaceutical company to report first quarter financial results, and investors across the industry are interested in hearing how the COVID-19 pandemic is impacting the sector's fundamental business dynamics.

SC2004_1-Quarter_229441972_1200.jpg
First quarter earnings may offer some clarity on business dynamics • Source: Shutterstock

The first quarter sales and earnings reporting season begins for the industry on 14 April with Johnson & Johnson, which will present the first tangible opportunity to hear directly from industry leaders about how the sector's business fundamentals have been impacted by the global outbreak of COVID-19.

Investors will be anxious to hear details on a wide range of potential business concerns raised by the pandemic: the...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip